Myeloperoxidase (MPO)+ neutrophils releasing interleukin-17 (IL-17) are a favorable prognostic factor in esophageal squamous cell carcinoma (ESCC). This evidence concerns the gene IL17A and esophageal squamous cell carcinoma.